Recovery from propofol anaesthesia supplemented with remifentanil
We have examined the effects on recovery end-points of supplementation of a propofol-based anaesthetic with remifentanil. After induction of anaesthesia with propofol and remifentanil 1.0 μg kg−1, 15 patients each were randomly allocated to target plasma propofol concentrations of 2, 3, 4 or 5 μg ml...
Saved in:
Published in: | British journal of anaesthesia : BJA Vol. 86; no. 3; pp. 361 - 365 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford
Elsevier Ltd
01-03-2001
Oxford University Press Oxford Publishing Limited (England) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We have examined the effects on recovery end-points of supplementation of a propofol-based anaesthetic with remifentanil. After induction of anaesthesia with propofol and remifentanil 1.0 μg kg−1, 15 patients each were randomly allocated to target plasma propofol concentrations of 2, 3, 4 or 5 μg ml−1for maintenance of anaesthesia. Remifentanil was administered by infusion for supplementation in doses required for maintenance of adequate anaesthesia. All patients received 50% nitrous oxide in oxygen and ventilation was controlled. The total amount of drugs used and times to different recovery end-points were recorded. Cognitive function was also assessed using a Mini-Mental State questionnaire. The median dose of remifentanil for maintenance of adequate anaesthesia (excluding the initial bolus dose) in the four groups was 0.21, 0.15, 0.11 and 0.13 μg kg−1 min−1 respectively (P=0.0026). The median times to eye opening and orientation were shortest in the 2 μg ml−1 group [6.0 and 6.5 min, 8.5 and 10.8 min, 13.4 and 15.8 min, and 14.2 and 19.5 min respectively in the propofol 2, 3, 4, and 5 μg ml−1 groups respectively (P<0.001)]. The times to discharge from the recovery ward and the Mini-Mental State scores were not significantly different. |
---|---|
ISSN: | 0007-0912 1471-6771 |
DOI: | 10.1093/bja/86.3.361 |